# Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC – FDA Inspection, Feb 11, 2026

Source: https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/97de66a3-38df-4231-8616-827b2267fbc3
Source feed: FDA_Inspections

> FDA inspection 1304580 of Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC, February 11, 2026. Classification: No Action Indicated (NAI). 16 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1304580
- Company Name: Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC
- Inspection Date: 2026-02-11
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Citation Count: 0

## Related Documents

- [FDA Inspection 1331288 - 2026-08-06](https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/3a30f17e-b96b-4038-afdf-5086e1071b60)
- [FDA Inspection 1311392 - 2026-04-08](https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/c5b9683d-dfc5-496a-afe9-353614bb2207)
- FDA Inspection 1223617 - 2023-10-13
- [FDA Inspection 1218069 - 2023-09-19](https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/f4363d29-0083-495d-94cb-2f6416bd0726)
- [FDA Inspection 1092777 - 2019-05-03](https://www.keypedia.com/records/fda_inspections/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/87adb2fd-61ee-44d3-961b-a549d4c21ccc)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/matthew-c-watson/a1594b84-f65a-42f9-a06d-a68a49eb4b28)

Company: https://www.keypedia.com/companies/wyeth-biopharma-division-of-wyeth-pharmaceuticals-llc/0de9118f-18ec-45b8-b757-44f97c13c29c